The effect of escitalopram on metabolic parameters in patients with major depressive disorder, generalised anxiety disorder, and panic disorder: A prospective 6-month follow-up study

Highlights ► We looked at the effect of escitalopram on metabolic parameters in patients with MDD, GAD, and PD. ► Symptoms improved concurrently with minor changes in metabolic parameters. ► Escitalopram appears to have minimal effects on components of the metabolic syndrome. ► Small sample size, la...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Asian journal of psychiatry 2013-06, Vol.6 (3), p.256-257
Hauptverfasser:	Peh, Andrew Lai Huat, Nieng, Chan Herng, Ling, Yap Hwa, Kheng, Tay Woo, Neng, Tan Sheng, Koon, Ong Guan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anxiety Disorders - complications Anxiety Disorders - drug therapy Citalopram - therapeutic use Depressive Disorder, Major - complications Female Follow-Up Studies Humans Internal Medicine Male Panic Disorder - complications Panic Disorder - drug therapy Prospective Studies Psychiatry Serotonin Uptake Inhibitors - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights ► We looked at the effect of escitalopram on metabolic parameters in patients with MDD, GAD, and PD. ► Symptoms improved concurrently with minor changes in metabolic parameters. ► Escitalopram appears to have minimal effects on components of the metabolic syndrome. ► Small sample size, lack of placebo and power limit the interpretation of the results.
ISSN:	1876-2018 1876-2026
DOI:	10.1016/j.ajp.2012.12.009